However, the FXR activated by GW4064 and CDCA in R2C cells binds to steroidogenic factor 1 (SF-1) response site in the promoter region of aromatase and inhibits its activity thereby blocking estrogen signalling and reducing tumour cell growth [231]. This evidence concerns the gene NR1H4 and neoplasm.